Director, Global Patient Recruitment and Engagement, Alexion, AstraZeneca Rare Disease
Deborah Howe is Director, Global Patient Recruitment and Engagement at Alexion, Astra Zeneca Rare Disease. In this role, she leads the strategic development and implementation of a framework to support planning and delivery of global patient finding and engagement strategies for Alexion Rare Disease studies that leverage patient voice, strategic partnerships, healthcare data, and technologies.
She also partners with Patient Experience and Patient Advocacy teams to lead Friction Coefficient activities (patient, caregiver, investigative site) to assess clinical trial burden with the goal to influence protocol design and ensure mitigation and support services are embedded at the study level and based on the insights gained.
Prior to joining Alexion, Deborah has worked at Celgene and Bristol Myers Squibb and has over 20 years of experience in patient recruitment in roles of increasing responsibilities and across various stages of drug development and therapeutic areas.
Deborah enjoys participating in industry activities and working groups and her greatest passion is learning patient insights and turning them into meaningful actions.